drugset / Trial / NCT03952234

Summary

The main purpose of this study is to determine the safest maximum dose of an amino acid, citrulline, which will be used as potential treatment for adult patients with a disorder of energy metabolism called Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). Once established, this dose will be used in a future clinical trial.

Timeline

Start
2021-04-22
Primary completion
2024-04-30
Completion
2024-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject L-citrulline Other / unclassified

Indications